VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $268,000 | -19.5% | 1,500 | 0.0% | 0.04% | -24.1% |
Q2 2015 | $333,000 | +11.7% | 1,500 | 0.0% | 0.06% | +7.4% |
Q1 2015 | $298,000 | -9.4% | 1,500 | -34.8% | 0.05% | -21.7% |
Q4 2014 | $329,000 | +8.9% | 2,300 | 0.0% | 0.07% | +19.0% |
Q3 2014 | $302,000 | +4.1% | 2,300 | 0.0% | 0.06% | +7.4% |
Q2 2014 | $290,000 | -4.3% | 2,300 | 0.0% | 0.05% | -6.9% |
Q1 2014 | $303,000 | +12.2% | 2,300 | 0.0% | 0.06% | +7.4% |
Q4 2013 | $270,000 | -28.2% | 2,300 | -36.1% | 0.05% | -32.5% |
Q3 2013 | $376,000 | +21.3% | 3,600 | 0.0% | 0.08% | +23.1% |
Q2 2013 | $310,000 | – | 3,600 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |